Incidence and prognostic factors of primary thyroid lymphoma and construction of prognostic models for post-chemotherapy and postoperative patients: a population-based study

被引:6
作者
Xiang, Nan [2 ]
Dong, Fangyuan [2 ]
Zhan, Xuebing [2 ]
Wang, Shuhan [2 ]
Wang, Junjie [2 ]
Sun, Entao [1 ]
Chen, Bing [2 ]
机构
[1] Wannan Med Coll, Dept Hlth Inspect & Quarantine, Wenchang West Rd 22, Wuhu, Anhui, Peoples R China
[2] Wannan Med Coll, Dept Pathol, Wenchang West Rd 22, Wuhu, Anhui, Peoples R China
基金
中国国家自然科学基金;
关键词
Thyroid lymphoma; Incidence; Treatment; Prognosis; Nomogram;
D O I
10.1186/s12902-021-00732-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundPrimary thyroid lymphoma (PTL) is a rare thyroid malignancy, there are few large sample studies on PTL and no standardized treatment regimen has been established due to the rarity. The aims of this study were to explore the incidence and prognostic factors of PTL and construct visual prognostic prediction models for post-chemotherapy and postoperative patients.MethodsThe incidence of PTL in 1975-2017 was extracted from the US Surveillance, Epidemiology, and End Results (SEER) database, then assessed using joinpoint regression software. A total of 1616 eligible PTL patients diagnosed in 1998-2016 were brought into prognostic analysis. Multivariate Cox regression analyses were carried out to reveal independent prognostic elements for overall survival (OS) and cancer-specific survival (CSS).ResultsPTL incidence showed a relatively steady increase in 1975-1994, which annual percent change (APC) was 4.0%, and steady decreasing in 1994-2017(APC -2.4%). Age, marital status, lymphoma Ann Arbor stage, histological subtypes, surgery, chemotherapy, and radiation were significantly correlated to OS and CSS. Nomograms were constructed to predict OS and CSS in post-chemotherapy and postoperative PTL patients separately, and were verified to have good reliability.ConclusionsThe incidence of PTL increased and subsequently decreased. We revealed the prognostic implications and constructed reliable nomograms for post-chemotherapy and postoperative PTL patients.
引用
收藏
页数:15
相关论文
共 26 条
  • [1] Primary thyroid lymphoma: The 40 year experience of a UK lymphoma treatment centre
    Alzouebi, M.
    Goepel, J. R.
    Horsman, J. M.
    Hancock, B. W.
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (06) : 2075 - 2080
  • [2] Thyroid diffuse large B cell lymphoma (DLBCL) following thyroid medullary cancer: long-term complete remission with R-CHOP therapy
    Dai, Chong-Wen
    Zhang, Guang-Sen
    Pei, Min-Fei
    Shen, Jian-Kai
    [J]. ANNALS OF HEMATOLOGY, 2009, 88 (07) : 701 - 702
  • [3] Malignant lymphoma of the thyroid gland - A clinicopathologic study of 108 cases
    Derringer, GA
    Thompson, LDR
    Frommelt, RA
    Bijwaard, KE
    Heffess, CS
    Abbondanzo, SL
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2000, 24 (05) : 623 - 639
  • [4] DORIA R, 1994, CANCER-AM CANCER SOC, V73, P200, DOI 10.1002/1097-0142(19940101)73:1<200::AID-CNCR2820730135>3.0.CO
  • [5] 2-#
  • [6] Primary thyroid lymphoma
    Dundar, Halit Ziya
    Sarkut, Pinar
    Kirdak, Turkay
    Korun, Nusret
    [J]. TURKISH JOURNAL OF SURGERY, 2016, 32 (01) : 75 - 77
  • [7] Prognosis of primary thyroid lymphoma: Demographic, clinical, and pathologic predictors of survival in 1,408 cases
    Graff-Baker, Amanda
    Roman, Sanziana A.
    Thomas, Daniel C.
    Udelsman, Robert
    Sosa, Julie Ann
    [J]. SURGERY, 2009, 146 (06) : 1105 - 1115
  • [8] Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone:: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group
    Hiddemann, W
    Kneba, M
    Dreyling, M
    Schmitz, N
    Lengfelder, E
    Schmits, R
    Reiser, M
    Metzner, B
    Harder, H
    Hegewisch-Becker, S
    Fischer, T
    Kropff, M
    Reis, HE
    Freund, M
    Wörmann, B
    Fuchs, R
    Planker, M
    Schimke, J
    Eimermacher, H
    Trümper, L
    Aldaoud, A
    Parwaresch, R
    Unterhalt, M
    [J]. BLOOD, 2005, 106 (12) : 3725 - 3732
  • [9] CANCER RISKS IN PATIENTS WITH CHRONIC LYMPHOCYTIC THYROIDITIS
    HOLM, LE
    BLOMGREN, H
    LOWHAGEN, T
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (10) : 601 - 604
  • [10] PRIMARY B-CELL LYMPHOMA OF THE THYROID AND ITS RELATIONSHIP TO HASHIMOTOS THYROIDITIS
    HYJEK, E
    ISAACSON, PG
    [J]. HUMAN PATHOLOGY, 1988, 19 (11) : 1315 - 1326